Private Asset Management Inc Eli Lilly & CO Transaction History

Private Asset Management Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 03, 2019	SELL	$111.31 - $131.02 $383,240 - $451,101	-3,443 Closed	0 $0
Q4 2018 Jan 08, 2019	SELL	$105.9 - $118.64 $1.29 Million - $1.44 Million	-12,147 Reduced 77.92%	3,443 $399,000
Q2 2018 Jul 10, 2018	BUY	$75.7 - $86.88 $1.18 Million - $1.35 Million	15,590 New	15,590 $1.21 Million

4,010

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Private Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Private Asset Management Inc with notifications on news.